121 related articles for article (PubMed ID: 18839132)
61. Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: A systematic review and meta-analysis.
Chen YL; Qiao YC; Xu Y; Ling W; Pan YH; Huang YC; Geng LJ; Zhao HL; Zhang XX
Immunol Lett; 2017 Jun; 186():52-58. PubMed ID: 28414180
[TBL] [Abstract][Full Text] [Related]
62. A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.
Roscioni SS; de Zeeuw D; Hellemons ME; Mischak H; Zürbig P; Bakker SJ; Gansevoort RT; Reinhard H; Persson F; Lajer M; Rossing P; Lambers Heerspink HJ
Diabetologia; 2013 Feb; 56(2):259-67. PubMed ID: 23086559
[TBL] [Abstract][Full Text] [Related]
63. Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes.
Yeo ES; Hwang JY; Park JE; Choi YJ; Huh KB; Kim WY
Yonsei Med J; 2010 Jul; 51(4):519-25. PubMed ID: 20499416
[TBL] [Abstract][Full Text] [Related]
64. Social Determinants of Health Are Associated with Markers of Renal Injury in Adolescents with Type 1 Diabetes.
Cummings LAM; Clarke A; Sochett E; Daneman D; Cherney DZ; Reich HN; Scholey JW; Dunger DB; Mahmud FH
J Pediatr; 2018 Jul; 198():247-253.e1. PubMed ID: 29752172
[TBL] [Abstract][Full Text] [Related]
65. [DIAGNOSTIC MARKERS FOR CHRONIC PANCREATITIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH DIFFERENT PHENOTYPE].
Zhuravlyova LV; Shekhovtsova Y A
Eksp Klin Gastroenterol; 2015; (6):47-52. PubMed ID: 26817104
[TBL] [Abstract][Full Text] [Related]
66. [ROLE OF C-REACTIVE PROTEIN AND TUMOR NECROSIS FACTOR-α IN IMMUNOREGULATION SYSTEM IN PATIENTS WITH CONCOMITANT COURSE OF CHRONIC PANCREATITIS AND TYPE 2 DIABETES MELLITUS].
Zhuravlyova LV; Shekhovtsova YO
Eksp Klin Gastroenterol; 2016; (6):33-6. PubMed ID: 30280549
[TBL] [Abstract][Full Text] [Related]
67. Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: Association with microinflammation.
Kawamura T; Umemura T; Umegaki H; Imamine R; Kawano N; Tanaka C; Kawai M; Minatoguchi M; Kusama M; Kouchi Y; Watarai A; Kanai A; Nakashima E; Hotta N
J Diabetes Investig; 2014 Sep; 5(5):597-605. PubMed ID: 25411629
[TBL] [Abstract][Full Text] [Related]
68. A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus.
Ng DP; Salim A; Liu Y; Zou L; Xu FG; Huang S; Leong H; Ong CN
Diabetologia; 2012 Feb; 55(2):499-508. PubMed ID: 22038517
[TBL] [Abstract][Full Text] [Related]
69. The role of C-reactive protein in type 2 diabetes and its macrovascular complications in Chinese.
Wu W; Liu G; Yu J; Zhang J; Wang X; Wang X; Kasai K; Wu W
Diabetes Res Clin Pract; 2003 Aug; 61(2):143-4. PubMed ID: 12951284
[No Abstract] [Full Text] [Related]
70. Clinical significance of microalbuminuria in high-risk patients with coronary artery disease.
Kojima S; Ogawa H
Circ J; 2011; 75(12):2765-6. PubMed ID: 22040939
[No Abstract] [Full Text] [Related]
71. [Chemical study of an isolated albuminuria which appeared during diabetes].
HARVIER P; FROMENT P; RANGIER M
C R Seances Soc Biol Fil; 1945; 139(3-4):161-4. PubMed ID: 21003350
[No Abstract] [Full Text] [Related]
72. Author Correction: GWAS for the composite traits of hematuria and albuminuria.
Gagliano Taliun SA; Dinsmore IR; Mirshahi T; Chang AR; Paterson AD; Barua M
Sci Rep; 2024 Jan; 14(1):1125. PubMed ID: 38212389
[No Abstract] [Full Text] [Related]
73. Erratum. Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes. Diabetes 2012;61:2134-2145.
Wang Z; Cheng Z; Cristofaro V; Li J; Xiao X; Gomez P; Ge R; Gong E; Strle K; Sullivan MP; Adam RM; White MF; Olumi AF
Diabetes; 2021 Jun; 70(6):1416. PubMed ID: 33980694
[No Abstract] [Full Text] [Related]
74. Correction: Type 2 Diabetes.
Ann Intern Med; 2021 May; 174(5):735. PubMed ID: 33999690
[No Abstract] [Full Text] [Related]
75. Cohort profile: the Singapore diabetic cohort study.
Luo M; Tan LWL; Sim X; Ng MKH; Van Dam R; Tai ES; Chia KS; Tang WE; Seah DE; Venkataraman K
BMJ Open; 2020 May; 10(5):e036443. PubMed ID: 32474429
[TBL] [Abstract][Full Text] [Related]
76. Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis.
Gohda T; Maruyama S; Kamei N; Yamaguchi S; Shibata T; Murakoshi M; Horikoshi S; Tomino Y; Ohsawa I; Gotoh H; Nojiri S; Suzuki Y
Sci Rep; 2017 Mar; 7():43520. PubMed ID: 28256549
[TBL] [Abstract][Full Text] [Related]
77. Cytokines profile and its correlation with endothelial damage and oxidative stress in patients with type 1 diabetes mellitus and nephropathy.
Pestana RM; Domingueti CP; Duarte RC; Fóscolo RB; Reis JS; Rodrigues AM; Martins LB; Sousa LP; Lage DP; Ferreira CN; Ferreira AV; Fernandes AP; Gomes KB
Immunol Res; 2016 Aug; 64(4):951-60. PubMed ID: 27307060
[TBL] [Abstract][Full Text] [Related]
78. Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.
Pavkov ME; Weil EJ; Fufaa GD; Nelson RG; Lemley KV; Knowler WC; Niewczas MA; Krolewski AS
Kidney Int; 2016 Jan; 89(1):226-34. PubMed ID: 26398493
[TBL] [Abstract][Full Text] [Related]
79. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
[TBL] [Abstract][Full Text] [Related]
80. Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors.
Gohda T; Tomino Y
Curr Diab Rep; 2013 Aug; 13(4):560-6. PubMed ID: 23657763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
